456 studies found for:    PAH
Show Display Options
Rank Status Study
1 Recruiting Hormonal, Metabolic, and Signaling Interactions in PAH
Conditions: Idiopathic Pulmonary Arterial Hypertension;   Heritable Pulmonary Arterial Hypertension;   Scleroderma Associated Pulmonary Arterial Hypertension;   Appetite Suppressant Associate PAH
Intervention:
2 Active, not recruiting Training With Whole Body Vibration Device in Patients With PAH
Condition: Pulmonary Artery Hypertension
Intervention: Device: Exercise Group Galileo PAH
3 Active, not recruiting Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Conditions: Pulmonary Arterial Hypertension;   Pulmonary Hypertension
Interventions: Drug: Nitric Oxide;   Other: Placebo
4 Unknown  Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
Conditions: Thalassemia Major;   Thalassemia Intermedia;   Pulmonary Arterial Hypertension
Intervention: Other: Physician standard-of-care according to ESC/ERS Guidelines
5 Recruiting BEET PAH: a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Dietary Supplement: Beetroot juice
6 Completed PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: PSA-Activated PSA-PAH1
7 Recruiting Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Conditions: Pulmonary Arterial Hypertension;   PAH
Intervention: Drug: Macitentan
8 Recruiting Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Condition: Pulmonary Arterial Hypertension
Intervention:
9 Active, not recruiting Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
Condition: Life Change Events
Interventions: Procedure: Pulmonary Arterial Denervation (PADN);   Drug: Sildenafil;   Drug: Bosentan;   Drug: Prostacyclin
10 Terminated Obstructive Sleep Apnea in Pulmonary Arterial Hypertension (OSA in PAH)
Conditions: Pulmonary Arterial Hypertension;   Obstructive Sleep Apnea
Intervention:
11 Completed Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Other: Blood draw
12 Recruiting Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
Condition: PAH
Intervention: Drug: oral treprostinil
13 Recruiting Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
14 Terminated FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Placebo;   Drug: FK506 level < 2 ng/ml;   Drug: FK506 level 2-3 ng/ml;   Drug: FK506 level 3-5 ng/ml
15 Completed Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
Condition: Pulmonary Arterial Hypertension
Intervention:
16 Terminated
Has Results
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: treprostinil;   Device: Crono Five ambulatory pump
17 Completed Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: inhaled prostacyclin;   Drug: prostacyclin;   Drug: subcutaneous and intravenous prostacyclin;   Drug: oral ERA;   Drug: oral PDE5 inhibitors
18 Recruiting Ventricular Reversed Remodeling After LTX in PAH Patients
Condition: Pulmonary Arterial Hypertension
Intervention:
19 Active, not recruiting Auto-immunity and Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   HIV Infection;   Congenital Heart Defect;   Systemic Sclerosis;   Connective Tissue Disease
Interventions: Procedure: skin biopsy;   Other: Blood Sample
20 Completed
Has Results
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxentan sodium

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years